...
机译:克拉来霉素(比亚新)-来那度胺低剂量地塞米松(BiRd)与来那度胺-低剂量地塞米松(Rd)对新诊断的骨髓瘤
Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota;
|Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota;
Division of Hematology and Medical Oncology, Department of Medicine, Center for Lymphoma and Myeloma, Weill-Cornell Medical College, New York Presbyterian Hospital-Cornell Medical Center, New York, New York;
Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota;
|Division of Hematology and Medical Oncology, Department of Medicine, Center for Lymphoma and Myeloma, Weill-Cornell Medical College, New York Presbyterian Hospital-Cornell Medical Center, New York, New York;
|Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota;
|Division of Hematology and Medical Oncology, Department of Medicine, Center for Lymphoma and Myeloma, Weill-Cornell Medical College, New York Presbyterian Hospital-Cornell Medical Center, New York, New York;
Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota;
|Division of Hematology and Medical Oncology, Department of Medicine, Center for Lymphoma and Myeloma, Weill-Cornell Medical College, New York Presbyterian Hospital-Cornell Medical Center, New York, New York;
|Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota;
|Department of Pathology, Weill-Cornell Medical College, New York Presbyterian Hospital-Cornell Medical Center, New York, New York;
Division of Hematology and Oncology, Mayo Clinic College of Medicine, Jacksonville, Florida;
Division of Hematology and Medical Oncology, Department of Medicine, Center for Lymphoma and Myeloma, Weill-Cornell Medical College, New York Presbyterian Hospital-Cornell Medical Center, New York, New York;
Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota;
Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota;
|Division of Hematology and Oncology, Mayo Clinic College of Medicine, Scottsdale, Arizona;
|Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota;
|Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota;
|Division of Hematology and Oncology, Mayo Clinic College of Medicine, Scottsdale, Arizona;
|Division of Hematology and Medical Oncology, Department of Medicine, Center for Lymphoma and Myeloma, Weill-Cornell Medical College, New York Presbyterian Hospital-Cornell Medical Center, New York, New York|;
机译:克拉来霉素(比亚新)-来那度胺低剂量地塞米松(BiRd)与来那度胺-低剂量地塞米松(Rd)用于新诊断的骨髓瘤。
机译:BiRD(Biaxin(克拉霉素)/ Revlimid(来那度胺)/地塞米松)联合治疗可在未治疗的症状性多发性骨髓瘤患者中获得较高的完全缓解和总体缓解率。
机译:加拿大回顾性的多中心研究比较硼佐米,环磷酰胺和地塞米松(Cybord)的组合与硼替佐米,沙利度胺和地塞米松(VTD)与硼喹啉和地塞米松(VD)进行新诊断的多发性脑膜患者,其中有资格获得自体造血干细胞移植(HCT)
机译:风险适应的静脉内莫尔甘蔗用佐剂沙利度胺和地塞米松,用于新诊断的未经治疗的全身淀粉样蛋白症患者:II期试验的中期报告
机译:在诊断为足底筋膜炎的患者中使用4 mg / ml地塞米松与5%乙酸进行离子电渗疗法的有效性:初步发现。
机译:Clarithromycin(Biadxin)-Lenalidomide-低剂量地塞米松(鸟类)与新诊断术骨髓瘤的Lenalidomide-Low-Dee Dexamethasone(RD)
机译:自体移植(ASCT)对多发性骨髓瘤(MM)进行低剂量沙利度胺,地塞米松和克拉霉素(BIAXIN)(BLT-D)的维持治疗